Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 11/20 | 0.39 |
| ▸ | RXRA | P19793 | 7/20 | 0.39 |
| ▸ | RARG | P13631 | 7/20 | 0.39 |
| ▸ | RARA | P10276 | 8/20 | 0.37 |
| ▸ | RXRB | P28702 | 5/20 | 0.36 |
| ▸ | RXRG | P48443 | 5/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | FABP4 | P15090 | 2/20 | 0.31 |
| ▸ | FABP3 | P05413 | 1/20 | 0.31 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.31 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.31 |
| ▸ | HTR7 | P34969 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
| ▸ | HNF4A | P41235 | 1/20 | 0.30 |
| ▸ | JAK2 | O60674 | 1/20 | 0.30 |
| ▸ | JAK3 | P52333 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27395020 | 0.86 | RARB (0.41) | RARBRXRARARGRARARXRB | |
| SCHEMBL24442968 | 0.86 | RARB (0.39) | RARBRXRARARGRARARXRB | |
| SCHEMBL24442807 | 0.82 | RARB (0.43) | RARBRXRARARGRARARXRB | |
| SCHEMBL24005343 | 0.82 | TP53 (0.43) | RARBRARGRARATP53CYP1A2 | |
| SCHEMBL31676214 | 0.81 | RXRA (0.36) | RARBRXRARARGRARARXRB | |
| SCHEMBL27395223 | 0.80 | RARB (0.50) | RARBRXRARARGRARATP53 | |
| SCHEMBL29945232 | 0.79 | RARB (0.46) | RARBRXRARARGRARARXRB | |
| SCHEMBL23442800 | 0.79 | RARB (0.46) | RARBRXRARARGRARARXRB | |
| SCHEMBL23442477 | 0.78 | NPSR1 (0.47) | RARBRXRARARGRXRBRXRG | |
| SCHEMBL31375644 | 0.78 | RARB (0.40) | RARBRXRARARGRARATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11780856-B2 | Compound and organic light-emitting device comprising same | LG CHEM, LTD. (KR) | 2023-10-10 | — | — | US | disclosed |
| EP-3919500-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2021-12-08 | — | — | EP | disclosed |
| WO-2021107681-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | 주식회사 엘지화학 | 2021-06-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11780856-B2 | Compound and organic light-emitting device comprising same | CRY1, CRY2, LEF1 | RARB 1767/4885RXRA 2187/4885RARG 1720/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.